Evogene Schedules First Quarter 2026 Financial Results Release
Evogene announced it will release its first quarter 2026 financial results on Wednesday, May 20, 2026. Following the release, company management will host a conference call at 9:00 AM ET to discuss the results. Evogene specializes in computational chemistry and generative AI for small molecule design in pharmaceutical and agricultural industries, using its ChemPass AI™ technology.
How this was made

The 30-second read
Why it matters
The upcoming earnings are a routine event; unless unexpected news emerges, minimal market disruption is anticipated.
Market read
While Evogene operates in promising sectors, its stock's low relevance score indicates limited immediate market impact from this news.
What to watch
Potential technological breakthroughs or partnerships announced during the conference call could significantly alter stock trajectory.
Background
Evogene is a biotech company leveraging AI for small molecule design, serving pharmaceutical and agricultural industries.
Ticker impact
Primary focus due to scheduled earnings release and company's specialization in AI and pharmaceuticals.
Potential for minor price movement (±5%) around the earnings date, contingent on actual results versus expectations.
The scheduled earnings release is a significant event; however, the neutral sentiment and lack of recent strong catalysts suggest limited immediate impact. Technical indicators and market conditions are not provided, limiting precise prediction.
Market effects
The earnings report could influence biotech and AI sectors, especially companies with similar AI-driven biotech solutions.
Limited regional impact expected; primarily relevant to US and Israeli markets where Evogene operates.
Low; Evogene's market cap and global influence are modest, and the news is company-specific.
Counterpoint
Positive surprise in earnings could lead to a sharp upward move, especially if results surpass expectations.
Key entities
- CompanyEvogene Ltd.
A biotech firm specializing in computational chemistry and AI-driven solutions for pharma and agriculture.
- TechnologyChemPass AI™
Evogene's proprietary AI platform for small molecule design.





